|
The 2nd
Technology Exchange Forum on
Medical Bio-Technology
The
second technology exchange forum of the country on the subject of
medical bio technology, by cooperation and partnership of the Presidential
Technology Cooperation Office,
Pardis
Technology
Park
and, the High Council of Bio Technology, held in November, 2007, in
Tehran. There were
holders of selected technologies in medical bio technology arena, university
professors, pharmaceutical investment companies, Iranian officials and, a group
of Iranian and non-Iranian authorities attended to this one-day forum.
The high lights of the represented topics at the forum
in biology arena
The
forum commenced by the speech of the Dr. Lotfi, the Secretary of the High
Council of Bio Technology. He quoted the emphasis of the Great Leader, on the
requirement of more attention to be paid on bio technology in the country and,
believed that through going on holding these events, a significant investment
will be achieved in this arena. He indicated the willingness of all of the
responsible authorities and related sectors to support the second technology exchange
forum and, establishing interactions between investors and bio technology
scientists and added, there is hope that through earnest endeavors and making
benefit of needed supports for these forums, effective roles can be played in
the field of new technologies, specially bio technology and, to reach the goal
of 20 year perspective of the region and, turning to the scientific pole.
Dr.
Dinarvand, Food & Drug Under Secretary in Ministry of Health, while
emphasizing on the necessity for activating the
deed
for development of the biotechnology in the country added that, bio
technological activities are followed diligently in our country, in a manner
that the operational measures are running for 10 products while, there are 14
products that have already entered in to the market. He pointed out the actions
done by the Ministry of Health and added; in the research centers affiliated to
this ministry, there are good deals of actions done regarding diagnosis of
diseases and, making the required infrastructure for treatment. He declared;
Iranian scientists know that the science development is a fundamental
development and, is not a short term or sectional movement. It proceeds on a
right track.
Dr.
Manavi, the TCO assistant in biological sciences and, the secretary of the
Forum, recognized the trilogy of districted vision, share demanding and,
disarrangement as the catastrophe, threatening the national
deed of biotechnology and added, the people and the
government must believe that, the novel technologies will result in achieving
objectives such as; elevating the income level of the society, job creating,
currency saving and, extending the non-oil export values. He stated; this forum
has made those who are involved at this arena to have a look to the output of their
activities and, apply in designing the continuation of the track. Besides, the
subjects introduced at this forum, will predispose the country’s situation for
development of biotechnology.
Willingness
of the applicants for investment
The forum continued by the technology applicants’
proclamation for investment, in order to commercialize the introduced
technologies at the forum. Mr. Hashemi, the Head of the
Novel
Industries
Center, Dr. Mohamadzadeh,
directing manager of Tamin Pharmaceutical Investment Company and, Dr.
Vatanpour, directing manager of Soha Pharmaceutical Company, each individually,
quoted the necessity of supporting the production and researchers to enter
their research attainments into the commercial market and, announced their
interest for financing, investment and participating in commercializing the
technologies.
The
feats of the Forum
There
were 37 technologies from
Iran
and, 6 technologies from;
Ukraine,
Korea,
China and,
India represented to the
secretariat of the Forum. Considering the time restriction of the forum and the
obligation for choosing the superior technologies, a committee formed,
comprising of the members of; the Biotechnology Association, Genetics
Association, Medical Biotechnology Network, Molecular Medical Network, The High
Council of Biotechnology, Technology Cooperation Office and, the Ministry of
Health, to select 4 out of the 43 represented technologies. In addition to take
the opportunity to be represented in the forum, the 4 selected technologies were
the candidates for the Biotechnology Award of the Year. These technologies,
which were granted with the first to fourth awards, respectively are;
1-
The technology of production,
research and development of the composition of Human βa Interferon Protein for
the treatment of MS.
2-
The technology of making
Fermanture.
3-
The technology of producing the
human live skin, comprising of derma and epidermal layers, destructible and, on
a biological compatible basis
4-
Diagnostic Kit for the antibodies
of HIV I,II viruses, by chemo-luminance method
The
executors of the above-mentioned technologies emphasized on the points such as;
application, market, unique features, transferring method, licenses,
permissions and, other point that are important regarding transferring of
technologies. The other technologies represented at an exhibition place, where
was determined for this purpose.
The
technologies represented by the foreign centers were:
-
The technology of design and making Bio-reactor at commercial scales,
by Professor Yup from
Korea
-
The technology of producing Bio-enzymes, by Dr. Vig from
India
Regarding
the strategic aspect of bio-reactor and, the interest of
Karaj
Biotechnology
Research
Center
for negotiating with the Korean researcher, the mentioned center recognized as
the particular addressed center for that technology. At this time, the
arrangements for two sides to negotiate, is being done by Iran National
Techmart. Also, Zakari Pharmaceutical Company of
Tabriz recognized as the special addressed
center for the Indian researcher. Following the made arrangements by Iran
National Techmart, the Indian researcher is going to visit
Iran by the
next month.
Subsequently,
a live video connection established to
Shanghai
Technology
Transferring
Center.
Firstly, they introduced their tenant companies and then, represented the
technologies. The technologies represented by the Chinese companies are:
-
Albumin-fusion Drug technology for long-acting effect
-
Bio informatics
Also,
during that connection, the both sides exchanged the information of the medical
biotechnology research centers.
Granting
the award of the year to the top biotechnology and, commendation of the
selected technologies
The Technology Exchange Forum on
Biotechnology, ended by commendation of the selected technologies. Among 43
technologies received by the secretariat, 10 selected as the candidates and, 4
provided with the award for the biotechnology of the year. These technologies,
which their titles are already mentioned above, were from the following
centers:
The
first technology: Sinagen Company, the holder of the technology: Dr. Hamedifar
The
second technology: Zist Fan Sanat Iran Company, the holder of the technology:
Eng. Molahosseini
The
third technology: Medical Biotechnology Network, the holder of the technology:
Dr. Shokrgozar
The
fourth technology: Pouya Zist Tak Company, the holder of the technology: Dr.
Farbod
At
this ceremony, where Mr. Sadjadi, the Head of TCO, Dr. Lotfi, the Secretary of
the High Council for Biotechnology and, Dr. Dinarvand, the Deputy of the Health
Minister were present, while commending and appreciating the executors of the
technologies, the commending plates and the award for the biotechnology of the
year allocated to them.
Considering
the strategic aspects of the country, being economic and competitive, suitable
local and global market, having primal sample, being close to the
commercialization phase and, holding the needed licenses and permissions, are
the features of the mentioned technologies.
The
award for the Technology of the Year, is being allocated to the best
technologies represented at the forums, aiming to motivate the researchers and
scientists, supporting the national projects and, promoting the culture of
exchanging technology. |
